SPY336.42+1.53 0.46%
DIA277.84+0.34 0.12%
IXIC11,303.39+135.88 1.22%

Catalent shares are trading higher after the company signed an agreement to provide drug substance manufacturing to AstraZeneca for its COVID-19 vaccine candidate.

Benzinga · 08/24/2020 13:45